Walden Group Healthcare M&A Blog

TopCon Acquires Italy-based Ophthalmic Imaging Device Producer VISIA Imaging

7/26/2021
TopCon Corporation, a $1.2 billion Japan-based developer of eyecare devices and software solutions worldwide has purchased Italy-based ophthalmic device manufacturer VISIA Imaging S.r.l. The acquisition provides Topcon with a portfolio of imaging devices focused on the anterior segment to complement its existing posterior segment imaging...
Read More
Surmodics Acquires Ireland–based Vetex Medical

7/12/2021
Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found...
Read More
Tecan Group Acquires Paramit for $1b

6/29/2021
Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan's entry into medical devices and enhances Paramit's...
Read More
DENTSPLY SIRONA Inc. Acquires Propel Orthodontics for $131M

6/14/2021
DENTSPLY SIRONA (Nasdaq: XRAY), a $3.3b provider of dental technologies, equipment and consumables has acquired Propel Orthodontics, developer of the VPro, a vibratory orthodontic device that seats aligners in 5 minutes a day for at-home use. The VPro device is used with Propel’s Fastrack Mobile App that patients can use to track usage and...
Read More
Japan-based Olympus Corporation Acquires Israel-based Medi-Tate

6/2/2021
Adds an in-office treatment for benign prostatic hyperplasia (BPH) treatment to Olympus’ leading urological devices portfolio. Medi-Tate's “iTind” has received FDA de Novo authorization and a European CE mark. Since November 2018, Olympus secured distribution rights to iTind via an initial investment. The incidence of BPH is one of...
Read More